Odontogenic tumors occur within the jaw bones and may be derived from odontogenic epithelium or ectomesenchyme or contain active components of both tissue types. We investigated the gene expression profile of enamel matrix proteins (EMPs), genes related to osteogenesis, and the mineralization process in odontogenic tumor cell populations focusing on an ameloblastoma (AB-1), a keratocystic odontogenic tumor (KCOT-1), and a calcifying epithelial odontogenic tumor (CEOT-1). All cell populations were shown to be epithelial in origin by CK14 expression. All tested EMPs were expressed by all odontogenic tumor cell types, with higher transcript levels seen in the AB-1 population especially for AMEL, AMBN, and ODAM. CEOT-1 cell populations showed a greater content of ALP-positive cells as well as higher ALP mRNA levels. Using qRT-PCR, we found a higher expression of 8 genes in the CEOT-1 compared to the AB-1 and KCOT-1. In this study we demonstrated the establishment of AB-1, KCOT-1 and CEOT-1 cell populations. The unique gene expression profiles of AB-1, KCOT-1, and CEOT-1 cells and their interactions with the surrounding microenvironment may support their unique tumor development, progression, and survival.

1.
Barnes, L., J.W. Eveson, P. Reichart, D. Sidransky (eds) (2005) World Health Organization Classification of Tumors: Pathology and Genetics of Head and Neck Tumours. Lyon, IARC Press, pp 306–307.
2.
Catón J., P. Bringas, Jr., M. Zeichner-David (2005) IGFs increase enamel formation by inducing expression of enamel mineralizing specific genes. Arch Oral Biol 50: 123–129.
3.
Chomette, G., M. Auriol, F. Guilbert (1984) Histoenzymological and ultrastructural study of a bifocal calcifying epithelial odontogenic tumor: characteristics of epithelial cells and histogenesis of amyloid-like material. Virchows Arch A Pathol Anat Histopathol 403: 67–76.
4.
Eversole, L.R. (1999) Malignant epithelial odontogenic tumors. Semin Diagn Pathol 16: 317–324.
5.
Heikinheimo, K., K.J. Jee, T. Niini, Y. Aalto, R.P. Happonen, I. Leivo, S. Knuutila (2002) Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res 81: 525–530.
6.
Kang, M.S., M.S. Park, S.W. Kwon, S.A. Ma, D.Y. Cho, D.Y. Kim, Y. Kim (2006) Amyloid-producing odontogenic tumour (calcifying epithelial odontogenic tumour) in the mandible of a Bengal tiger (Panthera tigris tigris). J Comp Pathol 134: 236–240.
7.
Kestler, D.P., J.S. Foster, S.D. Macy, C.L. Murphy, D.T. Weiss, A. Solomon (2008) Expression of odontogenic ameloblast-associated protein (ODAM) in dental and other epithelial neoplasms. Mol Med 14: 318–326.
8.
Liu J., T. Jin, S. Chang, H.H. Ritchie, A.J. Smith, B.H. Clarkson (2007) Matrix and TGF-beta-related gene expression during human dental pulp stem cell (DPSC) mineralization. In Vitro Cell Dev Biol Anim 43: 120–128.
9.
MacDougall, M., F. Thiemann, H. Ta, P. Hsu, L.S. Chen, M.L. Snead (1995) Temperature sensitive simian virus 40 large T antigen immortalization of murine odontoblast cell cultures: establishment of clonal odontoblast cell line. Connect Tiss Res 33: 97–103.
10.
Melrose, R.J. (1999) Benign epithelial odontogenic tumors. Semin Diagn Pathol 16: 271–287.
11.
Morimoto, C., M. Tsujimoto, S. Shimaoka, R. Shirasu, J. Takasu (1983) Ultrastructural localization of alkaline phosphatase in the calcifying epithelial odontogenic tumor. Oral Surg Oral Med Oral Pathol 56: 409–414.
12.
Solomon, A., C.L. Murphy, K. Weaver, D.T. Weiss, R. Hrncic, M. Eulitz, R.L. Donnell, K. Sletten, G. Westermark, P. Westermark (2003) Calcifying epithelial odontogenic (Pindborg) tumor-associated amyloid consists of a novel human protein. J Lab Clin Med 142: 348–355.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.